The Valley Desk

Clinical trial reportLeukemiaPublished

Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis

14 of 32 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Leukemia
Published
Subject terms
Humans; Multiple Myeloma; Dexamethasone; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Prognosis; Survival Rate; Follow-Up Studies; Aged; Middle Aged; Female; Male
PubMed ID
42637879
PubMed Central ID
PMC13713557
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal